skip to Main Content

Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk

Newsfeed image, light gray text on dark gray background
A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the European Journal of Gastroenterology & Hepatology.

Ben Boursi, M.D., from the Sheba Medical Center in Ramat Gan, Israel, and colleagues developed and internally validated a new model to predict PDA risk among those newly diagnosed with IFG. The analysis included 138,232 eligible patients with an initial IFG diagnosis (1995 to 2013). Read more . . . 


Back To Top